Health benefits of anthocyanin-containing foods, beverages, and supplements have unpredictable relation to gastrointestinal microbiota: a systematic review and meta-analysis of random clinical trials
![Health benefits of anthocyanin-containing foods, beverages, and supplements have unpredictable relation to gastrointestinal microbiota: a systematic review and meta-analysis of random clinical trials](/image/eyJ1cmkiOiJodHRwczovL3MzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL3N0YWNrYWRlbWljL3Byb2R1Y3Rpb24vcGFwZXIvMTM5MjY0OTUucG5nIiwiZm9ybWF0Ijoid2VicCIsInF1YWxpdHkiOjEwMCwibm9DYWNoZSI6dHJ1ZX0=.webp)
Anthocyanins are a type of natural pigment that has numerous health benefits. In recent years, the interaction of anthocyanins with gastrointestinal (GI) microbiota has been presented as a viable paradigm for explaining anthocyanin activities. The current study performed a systematic review and meta-analysis to determine the potential modulation of GI microbiota by anthocyanins in human health improvement. Clinical trials were retrieved from PubMed, Cochrane, Web of Knowledge (WOS), China Biology Medicine (CBM), China National Knowledge Infrastructure (CNKI), and ClinicalTrials.gov with no language restrictions. Eight clinical trials (252 participants) were selected from the 1121 identified studies and the relative phylum abundance extracted from the trials was analyzed using a random-effect model. Based on the analysis, anthocyanins had no effect on the relative abundance of Firmicutes [SMD: -0.46 (-1.25, 0.34), p value: 0.26], Proteobacteria [SMD: -0.32 (-0.73, 0.09), p value: 0.13] nor Actinobacteria [SMD: -0.19 (-0.50, 0.12), p value: 0.24], but influenced the abundance of Bacteroidetes [SMD: 0.84 (0.17, 1.52), p value: 0.01] when compared to placebo/control. No significant influence on the relative abundance was detected when the data were analyzed following the "Post-treatment vs. Pre-treatment" strategy. Our preliminary analysis revealed that the effects of anthocyanins on human GI microbiota vary between studies and individuals, and at the current stage, the clinical trials regarding the effects of anthocyanin interventions on human GI microbiota are lacking. More trials with larger sample sizes are needed to promote the clinical application of anthocyanins.
Publisher URL: https://www.sciencedirect.com/science/article/pii/S0271531723000271
DOI: 10.1016/j.nutres.2023.04.002
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.